Oxford Gene Technology
Oxford, United Kingdom· Est. 1995
Interrogate key biomarkers with our hybridisation-based FISH, NGS and array products for haematology, solid tumour, cytogenetics and rare disease. Learn more
Private Company
Total funding raised: $18M
About
Interrogate key biomarkers with our hybridisation-based FISH, NGS and array products for haematology, solid tumour, cytogenetics and rare disease. Learn more
Genetics & GenomicsDiagnostics
Funding History
2Total raised:$18M
Series A$15MMay 15, 2018
Grant$3MJun 15, 2016